{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:03:19Z","timestamp":1789038199088,"version":"build-2803163510"},"reference-count":30,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,3,15]]},"abstract":"<jats:p>The CD45 antigen is present on all cells of the hematopoietic lineage. Using a murine model, we have determined whether a lytic CD45 monoclonal antibody can produce persistent aplasia and whether it could facilitate syngeneic or allogeneic stem cell engraftment. After its systemic administration, we found saturating quantities of the antibody on all cells expressing the CD45 antigen, both in marrow and in lymphoid organs. All leukocyte subsets in peripheral blood were markedly diminished during or soon after anti-CD45 treatment, but only the effect on the lymphoid compartment was sustained. In contrast to the prolonged depletion of T and B lymphocytes from the thymus and spleen, peripheral blood neutrophils began to recover within 24 hours after the first anti-CD45 injection and marrow progenitor cells were spared from destruction, despite being coated with saturating quantities of anti-CD45. Given the transient effects of the monoclonal antibody on myelopoiesis and the more persistent effects on lymphopoiesis, we asked whether this agent could contribute to donor hematopoietic engraftment following nonmyeloablative transplantation. Treatment with anti-CD45 alone did not enhance syngeneic engraftment, consistent with its inability to destroy progenitor cells and permit competitive repopulation with syngeneic donor stem cells. By contrast, the combination of anti-CD45 and an otherwise inactive dose of total-body irradiation allowed engraftment of H2 fully allogeneic donor stem cells. We attribute this result to the recipient immunosuppression produced by depletion of CD45+ lymphocytes. Monoclonal antibodies of this type may therefore have an adjunctive role in nonmyeloablative conditioning regimens for allogeneic stem cell transplantation.<\/jats:p>","DOI":"10.1182\/blood-2002-08-2379","type":"journal-article","created":{"date-parts":[[2003,2,27]],"date-time":"2003-02-27T18:28:53Z","timestamp":1046370533000},"page":"2434-2439","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":43,"title":["Anti-CD45\u2013mediated cytoreduction to facilitate allogeneic stem cell transplantation"],"prefix":"10.1182","volume":"101","author":[{"given":"Gerald G.","family":"Wulf","sequence":"first","affiliation":[{"name":"From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Li","family":"Luo","sequence":"additional","affiliation":[{"name":"From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Goodell","sequence":"additional","affiliation":[{"name":"From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm K.","family":"Brenner","sequence":"additional","affiliation":[{"name":"From the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111823001242200_B1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1470-2045(00)00153-4","article-title":"Haemopoietic stem-cell transplantation: recent progress and future promise.","volume":"1","author":"Craddock","year":"2000","journal-title":"Lancet Oncol."},{"key":"2019111823001242200_B2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00062752-200111000-00005","article-title":"Reducing transplant toxicity.","volume":"8","author":"Feinstein","year":"2001","journal-title":"Curr Opin Hematol."},{"key":"2019111823001242200_B3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood.V97.3.631","article-title":"Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.","volume":"97","author":"Giralt","year":"2001","journal-title":"Blood."},{"key":"2019111823001242200_B4","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.4049\/jimmunol.164.4.1793","article-title":"Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants.","volume":"164","author":"Liu","year":"2000","journal-title":"J Immunol."},{"key":"2019111823001242200_B5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/87687","article-title":"CD45: new jobs for an old acquaintance.","volume":"2","author":"Penninger","year":"2001","journal-title":"Nat Immunol."},{"key":"2019111823001242200_B6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1182\/blood.V85.4.1122.bloodjournal8541122","article-title":"Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 125I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.","volume":"85","author":"Matthews","year":"1995","journal-title":"Blood."},{"key":"2019111823001242200_B7","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood.V94.4.1237","article-title":"Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.","volume":"94","author":"Matthews","year":"1999","journal-title":"Blood."},{"key":"2019111823001242200_B8","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1182\/blood.V99.10.3566","article-title":"In vivo depletion of hematopoietic stem cells in the rat by an anti-CD45 (RT7) antibody.","volume":"99","author":"Dahlke","year":"2002","journal-title":"Blood."},{"key":"2019111823001242200_B9"},{"key":"2019111823001242200_B10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.iy.07.040189.002011","article-title":"The leukocyte common antigen family.","volume":"7","author":"Thomas","year":"1989","journal-title":"Annu Rev Immunol."},{"key":"2019111823001242200_B11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1749-6632.2001.tb03601.x","article-title":"Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.","volume":"938","author":"Feinstein","year":"2001","journal-title":"Ann N Y Acad Sci."},{"key":"2019111823001242200_B12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(97)03098-5","article-title":"Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukemia.","volume":"350","author":"Hongeng","year":"1997","journal-title":"Lancet."},{"key":"2019111823001242200_B13","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1182\/blood.V92.12.4581","article-title":"Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.","volume":"92","author":"Hale","year":"1998","journal-title":"Blood."},{"key":"2019111823001242200_B14","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V96.7.2419","article-title":"In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation [in process citation].","volume":"96","author":"Kottaridis","year":"2000","journal-title":"Blood."},{"key":"2019111823001242200_B15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.1994.tb04972.x","article-title":"CD45 isoform expression on human hemopoietic cells at different stages of development.","volume":"88","author":"Craig","year":"1994","journal-title":"Br J Haematol."},{"key":"2019111823001242200_B16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/icb.1997.68","article-title":"The role of CD45 and CD45-associated molecules in T cell activation.","volume":"75","author":"Altin","year":"1997","journal-title":"Immunol Cell Biol."},{"key":"2019111823001242200_B17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35053086","article-title":"CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling.","volume":"409","author":"Irie-Sasaki","year":"2001","journal-title":"Nature."},{"key":"2019111823001242200_B18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1172\/JCI0214794","article-title":"Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases.","volume":"109","author":"Hermiston","year":"2002","journal-title":"J Clin Invest."},{"key":"2019111823001242200_B19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/10428199609051610","article-title":"CD45 (leukocyte common antigen) expression in T and B lymphocyte subsets.","volume":"20","author":"Poppema","year":"1996","journal-title":"Leuk Lymphoma."},{"key":"2019111823001242200_B20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-1759(00)00228-3","article-title":"Immunophenotyping of leukemia.","volume":"243","author":"Campana","year":"2000","journal-title":"J Immunol Methods."},{"key":"2019111823001242200_B21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1084\/jem.172.1.363","article-title":"Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow.","volume":"172","author":"Lansdorp","year":"1990","journal-title":"J Exp Med."},{"key":"2019111823001242200_B22","first-page":"1228","article-title":"Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody.","volume":"52","author":"Matthews","year":"1992","journal-title":"Cancer Res."},{"key":"2019111823001242200_B23","first-page":"142a","article-title":"131 I-anti-CD45 antibody plus busulfan\/cyclophosphamide in matched related transplants for AML in first remission [abstract].","volume":"88","author":"Matthews","year":"1996","journal-title":"Blood."},{"key":"2019111823001242200_B24","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.4049\/jimmunol.142.12.4144","article-title":"Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.","volume":"142","author":"Gruber","year":"1989","journal-title":"J Immunol."},{"key":"2019111823001242200_B25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4049\/jimmunol.146.3.949","article-title":"Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis.","volume":"146","author":"Harvath","year":"1991","journal-title":"J Immunol."},{"key":"2019111823001242200_B26","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.4049\/jimmunol.147.8.2670","article-title":"Monoclonal antibodies to the leukocyte common antigen (CD45) inhibit IgE-mediated histamine release from human basophils.","volume":"147","author":"Hook","year":"1991","journal-title":"J Immunol."},{"key":"2019111823001242200_B27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/380717a0","article-title":"Prevention and reversal of renal allograft rejection by antibody against CD45RB.","volume":"380","author":"Lazarovits","year":"1996","journal-title":"Nature."},{"key":"2019111823001242200_B28","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.4049\/jimmunol.154.11.5725","article-title":"Generation of T cells with differential responses to alloantigens in CD45 exon 6-deficient mice.","volume":"154","author":"Kong","year":"1995","journal-title":"J Immunol."},{"key":"2019111823001242200_B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60595-7","article-title":"The role of CD45 in signal transduction.","volume":"66","author":"Justement","year":"1997","journal-title":"Adv Immunol."},{"key":"2019111823001242200_B30","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/6\/2434\/1263503\/h80603002434.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/6\/2434\/1263503\/h80603002434.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T12:47:19Z","timestamp":1682426839000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/6\/2434\/106584\/AntiCD45mediated-cytoreduction-to-facilitate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,15]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,3,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-08-2379","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3,15]]}}}